Page 4 - C Diff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from C Diff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In C Diff Today - Breaking & Trending Today

Exploring Doxycycline's Impact on C difficile Infections: An In-Depth Interview With Kari A. Mergenhagen, PharmD, BCPS, BCIDP

Published: November 7, 2023

Kari A. Mergenhagen, PharmD, BCPS, BCIDP, discusses the potential of doxycycline in reducing C difficile infections among hospitalized patients with pneumonia. This interview delves into doxycycline's influence on patients with a prior C difficile history, demographic generalizability, exclusion criteria, and concerns regarding antibiotic resistance.

Source: infectioncontroltoday.com

Related Topics:

Better Fecal Live Microbiota Outcomes Linked to Gut Microbiome Health

Published: October 25, 2023

New PUNCH CD3 analyses show patients who were treated with live fecal microbiota therapy improved their gut health at 8 weeks—which correlated with improved quality-of-life scores.

Source: hcplive.com

Related Topics:

British Columbia Paul Feuerstadt Yale University School Of Medicine Gastroenterology Center American College Of Gastroenterology C Difficile Quality Of Life Survey Cdiff American College Scientific Meeting Yale University School Life Survey Punch Cd3 C Difficile C Diff

Phase 1 Trial Demonstrates Safety, Tolerability of Autologous FMT

Published: October 17, 2023

Results showed autologous FMT was safe and well-tolerated but did not affect time to normalized intestinal habits compared to placebo.

Source: hcplive.com

Related Topics:

Johan Ursing Centers For Disease Karolinska Institute Department Of Infectious Diseases At Danderyd Hospital Karolinska Trial Alliance Karolinska Institute Johan Ursing Infectious Diseases Danderyd Hospital Disease Control Clostridium Difficile Accessed October C Diff Clostridioides Difficile Infection Fecal Microbiota Transplantation Phase 1

Antidepressant Use Linked to Increased Risk of Hospital-Onset C Diff

Published: October 16, 2023

Use of mirtazapine, nortriptyline, and trazodone among hospitalized patients was associated with a greater risk of CDI.

Source: hcplive.com

Related Topics:

United States Antoine Boustany Researchgate Antoine Boustany Us Centers For Disease Cleveland Clinic Disease Control Clostridium Difficile Accessed October C Diff Clostridioides Difficile Infection Clostridioides Difficile

Calprotectin, Microbiota Levels Can Predict C Diff Recurrence, Study Finds

Published: October 11, 2023

Age, fecal calprotectin level, toxin B PCR cycle threshold, immunosuppression, sex, and creatinine levels were identified as independent risk factors for developing recurrent CDI.

Source: hcplive.com

Related Topics:

Gregorio Mara Universitario Gregorio Mara Health Research Institute Hospital General Universitario Gregorio Mara C Diff Clostridioides Difficile Infection Microbial Genera Risk Index

Page 5 Page 6 Page 7 Page 8